Advertisement

Mental Health

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023

Jessica Ganga

Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
FDA
FDA
FDA Approves New Option for Postpartum Depression
03/20/2019
The FDA has approved a new treatment option that is the first drug approved by the FDA specifically for the treatment of postpartum depression in adult women.
03/20/2019
Depression
Depression
FDA Approves Nasal Spray for Depression
03/06/2019
The FDA has approved a new nasal spray, in conjunction with an oral antidepressant, for the treatment of adults with treatment-resistant depression.
03/06/2019
Schizophrenia
Schizophrenia
FDA Approves New Dosing Duration for Aristada
06/06/2017
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
06/06/2017